Douglas Jermasek - 18 Nov 2022 Form 3 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
EVP of Corporate Strategy
Signature
/s/ Douglas Jermasek
Issuer symbol
UNCY
Transactions as of
18 Nov 2022
Net transactions value
$0
Form type
3
Filing time
21 Nov 2022, 07:51:18 UTC
Next filing
23 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding UNCY Common Stock 70,400 18 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding UNCY Stock Options 18 Nov 2022 Common Stock 100,000 $2.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25,000 options vested on October 20, 2022 and the remainder vest over 36 months after the initial vesting.